| Title |
Sequential treatment of metastatic renal cell carcinoma patients after first-line vascular endothelial growth factor targeted therapy in a real-world setting: epidemiologic, noninterventional, retrospective–prospective cohort multicentre study / |
| Authors |
Česas, Alvydas ; Urbonas, Vincas ; Tulytė, Skaistė ; Jančiauskienė, Rasa ; Liutkauskienė, Sigita ; Grabauskytė, Ingrida ; Gaidamavičius, Ignas |
| DOI |
10.1007/s00432-023-04645-x |
| Full Text |
|
| Is Part of |
Journal of cancer research and clinical oncology.. New York : Springer. 2023, vol. 149, p. 6979-6988.. ISSN 0171-5216. eISSN 1432-1335 |
| Keywords [eng] |
mRCC ; PFS ; PFS2 ; Real-world data ; Treatment sequence ; VEGF |
| Abstract [eng] |
The purpose of our study was to determine whether data on the clinical effectiveness of second-line therapy collected in a real-world setting provide additional valuable information on the optimal sequence of metastatic renal cell carcinoma (mRCC) treatment. |
| Published |
New York : Springer |
| Type |
Journal article |
| Language |
English |
| Publication date |
2023 |
| CC license |
|
